The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future
Abstract
The estimated prevalence of non‐alcoholic fatty liver disease (NAFLD) worldwide is approximately 25%. However, the real prevalence of NAFLD and the associated disorders is unknown mainly because reliable and applicable diagnostic tests are lacking. This is further complicated by the lack of consensus on the terminology of different entities such as NAFLD or nonalcoholic steatohepatitis (NASH). Although assessing fatty infiltration in the liver is simple by ultrasound, the gold standard for the assessment of fibrosis, the only marker of progression towards more severe liver disease is still liver biopsy. Although other non‐invasive tests have been proposed, they must still be validated in large series. Because NAFL/NAFLD/NASH and related metabolic diseases represent an economic burden, finding an inexpensive method to diagnose and stage fatty liver is a priority. A translational approach with the use of cell and/or animal models could help to reach this goal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042
Self-citationThe Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Self-citationLavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,101
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Wong, R. J., Cheung, R., & Ahmed, A. (2014) · Hepatology · doi:10.1002/hep.26986 · Cited by 723
Feldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712
Piscaglia, F., Svegliati‐Baroni, G., Barchetti, A., Pecorelli, A., Marinelli, S., Tiribelli, C., Bellentani, S., & on behalf of the HCC‐NAFLD Italian Study Group (2016) · Hepatology · doi:10.1002/hep.28368 · Cited by 604
Self-citationAnimal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
Van Herck, M., Vonghia, L., & Francque, S. (2017) · Nutrients · doi:10.3390/nu9101072 · Cited by 392
Roberson, L. L., Aneni, E. C., Maziak, W., Agatston, A., Feldman, T., Rouseff, M., Tran, T., Blaha, M. J., Santos, R. D., Sposito, A., et al. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-14 · Cited by 305
Cusi, K., Chang, Z., Harrison, S., Lomonaco, R., Bril, F., Orsak, B., Ortiz-Lopez, C., Hecht, J., Feldstein, A. E., Webb, A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.042 · Cited by 273
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
Shen, J., Chan, H. L.-Y., Wong, G. L.-H., Choi, P. C.-L., Chan, A. W.-H., Chan, H.-Y., Chim, A. M.-L., Yeung, D. K.-W., Chan, F. K.-L., Woo, J., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.025 · Cited by 246
MP, D., R, S., I, R., S, S., R, P., & V, B. (2018) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.15.13.20 · Cited by 236
Joka, D., Wahl, K., Moeller, S., Schlue, J., Vaske, B., Bahr, M. J., Manns, M. P., Schulze-Osthoff, K., & Bantel, H. (2012) · Hepatology · doi:10.1002/hep.24734 · Cited by 184
Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
Sherif, Z. A., Saeed, A., Ghavimi, S., Nouraie, S.-M., Laiyemo, A. O., Brim, H., & Ashktorab, H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4143-0 · Cited by 179
Ajmera, V., Perito, E. R., Bass, N. M., Terrault, N. A., Yates, K. P., Gill, R., Loomba, R., Diehl, A. M., & Aouizerat, B. E. (2017) · Hepatology · doi:10.1002/hep.28776 · Cited by 179
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review
Ajmera, V. H., Terrault, N. A., & Harrison, S. A. (2017) · Hepatology · doi:10.1002/hep.29055 · Cited by 137
Mass Screening for Colorectal Cancer
Kronborg, O. (1984) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1984.12005675 · Cited by 129
He, X., Wu, X., Chen, R., Chen, C., Liu, X., Wu, B.-J., & Huang, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162368 · Cited by 129
In Vitro Models for the Study of Non-Alcoholic Fatty Liver Disease
C. Chavez-Tapia, N., Rosso, N., & Tiribelli, C. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794940842 · Cited by 86
Self-citationReview article: new treatments in non‐alcoholic fatty liver disease
Townsend, S. A., & Newsome, P. N. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14210 · Cited by 71
An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Marin, V., Rosso, N., Ben, M. D., Raseni, A., Boschelle, M., Degrassi, C., Němečková, I., Nachtigal, P., Avellini, C., Tiribelli, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158817 · Cited by 67
Self-citationQi, S., Xu, D., Li, Q., Xie, N., Xia, J., Huo, Q., Li, P., Chen, Q., & Huang, S. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.022 · Cited by 63
Giraudi, P. J., Barbero-Becerra, V. J., Marin, V., Chávez-Tapia, N. C., Tiribelli, C., & Rosso, N. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.12.006 · Cited by 54
Self-citationMarin, V., Gazzin, S., Gambaro, S. E., Ben, M. D., Calligaris, S., Anese, M., Raseni, A., Avellini, C., Giraudi, P. J., Tiribelli, C., et al. (2017) · Nutrients · doi:10.3390/nu9091006 · Cited by 49
Self-citationIGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD – a pilot study
Hagström, H., Stal, P. I., Hultcrantz, R. W., Brismar, K., & Ansurudeen, I. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1379556 · Cited by 45
Is it time to change NAFLD and NASH nomenclature?
Bellentani, S., & Tiribelli, C. (2017) · The Lancet Gastroenterology and Hepatology · doi:10.1016/s2468-1253(17)30146-2 · Cited by 39
Self-citationGiraudi, P. J., Gambaro, S. E., Arroyo, S. O., Chackelevicius, C. M., Giuricin, M., Silvestri, M., Macor, D., Crocè, L. S., Bonazza, D., Soardo, G., et al. (2017) · Liver International · doi:10.1111/liv.13505 · Cited by 10
Self-citation
Cited by
Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00523-4 · Cited by 757
Abenavoli, L., Izzo, A. A., Milić, N., Cicala, C., Santini, A., & Capasso, R. (2018) · Phytotherapy Research · doi:10.1002/ptr.6171 · Cited by 463
Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms
Dar, W. A., Sullivan, E., Bynon, J. S., Eltzschig, H., & Ju, C. (2019) · Liver International · doi:10.1111/liv.14091 · Cited by 397
Lazarus, J. V., Mark, H. E., Villota-Rivas, M., Palayew, A., Carrieri, P., Colombo, M., Ekstedt, M., Esmat, G., George, J., Marchesini, G., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.025 · Cited by 267
Impact of different ectopic fat depots on cardiovascular and metabolic diseases
Ferrara, D., Montecucco, F., Dallegri, F., & Carbone, F. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28821 · Cited by 195
Metadata
- Authors
- Araújo, A. R., Rosso, N., Bedogni, G., Tiribelli, C., & Bellentani, S.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2018-02
- Volume
- 38
- Issue
- S1
- Pages
- 47-51
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2791880774
- Cited by
- 401
- References
- 38
- FWCI
- 40.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.